Intraoperative radiotherapy for breast cancer: powerful evidence to change practice.
作者信息
Vaidya Jayant S, Bulsara Max, Baum Michael, Alvarado Michael, Bernstein Marcelle, Massarut Samuele, Saunders Christobel, Sperk Elena, Wenz Frederik, Tobias Jeffrey S
机构信息
Division of Surgery and Interventional Science, University College London, London, UK.
Department of Biostatistics, University of Notre Dame, Fremantle, WA, Australia.
出版信息
Nat Rev Clin Oncol. 2021 Mar;18(3):187-188. doi: 10.1038/s41571-021-00471-7.
Abstract
摘要
相似文献
1
Intraoperative radiotherapy for breast cancer: powerful evidence to change practice.乳腺癌术中放疗：改变实践的有力证据。
Nat Rev Clin Oncol. 2021 Mar;18(3):187-188. doi: 10.1038/s41571-021-00471-7.
2
Reply to 'Intraoperative radiotherapy for breast cancer: powerful evidence to change practice'.对《乳腺癌术中放疗：改变实践的有力证据》的回复
Nat Rev Clin Oncol. 2021 Mar;18(3):188-189. doi: 10.1038/s41571-021-00472-6.
3
Intraoperative radiotherapy for early breast cancer - insufficient evidence to change practice.早期乳腺癌术中放疗 - 证据不足，无法改变实践。
Nat Rev Clin Oncol. 2020 Dec;17(12):723-724. doi: 10.1038/s41571-020-00444-2.
4
Intraoperative radiotherapy for breast cancer.乳腺癌术中放疗
Lancet. 2014 Feb 15;383(9917):578-81. doi: 10.1016/S0140-6736(13)62304-1. Epub 2013 Nov 11.
5
Breast cancer: targeted intraoperative radiotherapy - one pit stop for breast cancer treatment.乳腺癌：术中靶向放疗——乳腺癌治疗的一站式方案
Nat Rev Clin Oncol. 2014 Jan;11(1):1. doi: 10.1038/nrclinonc.2013.226. Epub 2013 Nov 26.
6
Intraoperative radiotherapy for early breast cancer.早期乳腺癌的术中放疗
Lancet. 2010 Oct 2;376(9747):1142; author reply 1143-4. doi: 10.1016/S0140-6736(10)61531-0.
7
Intraoperative radiotherapy for early breast cancer.早期乳腺癌的术中放疗
Lancet. 2010 Oct 2;376(9747):1141; author reply 1143-4. doi: 10.1016/S0140-6736(10)61530-9.
8
Intraoperative radiotherapy for early breast cancer.早期乳腺癌的术中放疗
Lancet. 2010 Oct 2;376(9747):1142; author reply 1143-4. doi: 10.1016/S0140-6736(10)61532-2.
9
Intraoperative radiotherapy for early breast cancer.早期乳腺癌的术中放疗
Lancet. 2010 Oct 2;376(9747):1141; author reply 1143-4. doi: 10.1016/S0140-6736(10)61529-2.
10
[Partial breast irradiation with intraoperative electrons versus conventional external whole breast irradiation for early breast cancer. Results of the ELIOT trial].[早期乳腺癌术中电子线局部乳腺照射与传统全乳外照射的比较。ELIOT试验结果]
Strahlenther Onkol. 2014 Apr;190(4):422-4. doi: 10.1007/s00066-014-0556-x.
引用本文的文献
1
Global adoption of single-shot targeted intraoperative radiotherapy (TARGIT-IORT) for breast cancer-better for patients, better for healthcare systems.全球采用单次靶向术中放射治疗（TARGIT-IORT）治疗乳腺癌——对患者更好，对医疗系统更好。
Front Oncol. 2022 Aug 11;12:786515. doi: 10.3389/fonc.2022.786515. eCollection 2022.
2
Identification of pyroptosis related subtypes and tumor microenvironment infiltration characteristics in breast cancer.鉴定乳腺癌中的细胞焦亡相关亚型和肿瘤微环境浸润特征。
Sci Rep. 2022 Jun 23;12(1):10640. doi: 10.1038/s41598-022-14897-1.
本文引用的文献
1
Intraoperative radiotherapy for early breast cancer - insufficient evidence to change practice.早期乳腺癌术中放疗 - 证据不足，无法改变实践。
Nat Rev Clin Oncol. 2020 Dec;17(12):723-724. doi: 10.1038/s41571-020-00444-2.
2
Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised clinical trial.保乳术后单次剂量靶向术中放疗（TARGIT-IORT）治疗早期乳腺癌的长期生存和局部控制结果：TARGIT-A 随机临床试验。
BMJ. 2020 Aug 19;370:m2836. doi: 10.1136/bmj.m2836.
3
Estimating the Risks of Breast Cancer Radiotherapy: Evidence From Modern Radiation Doses to the Lungs and Heart and From Previous Randomized Trials.评估乳腺癌放疗风险：来自肺部和心脏现代辐射剂量及既往随机试验的证据
J Clin Oncol. 2017 May 20;35(15):1641-1649. doi: 10.1200/JCO.2016.72.0722. Epub 2017 Mar 20.
4
Reduced Mortality With Partial-Breast Irradiation for Early Breast Cancer: A Meta-Analysis of Randomized Trials.早期乳腺癌局部乳腺照射降低死亡率：随机试验的荟萃分析
Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2):259-265. doi: 10.1016/j.ijrobp.2016.05.008. Epub 2016 May 13.
5
Environmental and social benefits of the targeted intraoperative radiotherapy for breast cancer: data from UK TARGIT-A trial centres and two UK NHS hospitals offering TARGIT IORT.乳腺癌靶向术中放疗的环境和社会效益：来自英国TARGIT-A试验中心及两家提供TARGIT术中放疗的英国国民健康服务体系（NHS）医院的数据。
BMJ Open. 2016 May 9;6(5):e010703. doi: 10.1136/bmjopen-2015-010703.
6
Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials).乳腺癌试验中事件发生时间终点定义指南：DATECAN倡议（癌症试验中事件发生时间终点评估定义）的结果
Ann Oncol. 2015 Dec;26(12):2505-6. doi: 10.1093/annonc/mdv478. Epub 2015 Oct 13.
7
Risk of second non-breast cancer after radiotherapy for breast cancer: a systematic review and meta-analysis of 762,468 patients.乳腺癌放疗后发生第二种非乳腺癌的风险：对762468例患者的系统评价和荟萃分析
Radiother Oncol. 2015 Jan;114(1):56-65. doi: 10.1016/j.radonc.2014.10.004. Epub 2014 Nov 7.
8
Risk of ischemic heart disease in women after radiotherapy for breast cancer.乳腺癌放疗后女性患缺血性心脏病的风险。
N Engl J Med. 2013 Mar 14;368(11):987-98. doi: 10.1056/NEJMoa1209825.
9
Can the risk of secondary cancer induction after breast conserving therapy be reduced using intraoperative radiotherapy (IORT) with low-energy x-rays?保乳治疗后采用低能 X 射线术中放疗（IORT）能否降低继发癌症的风险？
Radiat Oncol. 2011 Dec 16;6:174. doi: 10.1186/1748-717X-6-174.
10
Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials: the STEEP system.辅助性乳腺癌试验中疗效终点标准化定义的提案：STEEP 系统。
J Clin Oncol. 2007 May 20;25(15):2127-32. doi: 10.1200/JCO.2006.10.3523.
Zotero 插件